Kuros Biosciences’ MagnetOs Granules FDA-Cleared for Expanded Spinal Indications
This is the second-ever bone graft to achieve clearance for standalone use in the spine based on human clinical data....
Feb 03, 2022,
Orthobiologics
ORTHOFLASH 
Study: Synergy Biomedical BioSphere Bone Graft Technology
Results address bone formation properties of a clinically accepted bone graft material, bioactive glass, and its optimization....
Jan 31, 2022,
Bone Solutions Launches Mg OSTEOINJECT Bone Void Filler
Mg OSTEOINJECT is the first injectable bone void filler in the U.S. to incorporate magnesium for bone health and development....
Jan 26, 2022,
OssDsign to Collect Data on Catalyst Bone Graft
OssDsign will launch a U.S. clinical registry to collect real-world data on Catalyst in spinal fusion applications....
Jan 13, 2022,
NuVasive Gains Clearance for Expanded Use of Attrax Putty
The expanded FDA clearance applies to indications for use with NuVasive's thoracolumbar spinal interbody portfolio....
Jan 05, 2022,
Neoss Launches NeoGenix XP Bone Substitute
NeoGenix XP more closely resembles natural bone vs. synthetic materials, such as hydroxyapatite or tricalcium phosphate....
Oct 25, 2021,
Access2Bone Announces Accreditation by The American Association of Tissue Banks
The company seeks to supply effective bone void fillers for patients with an exhausted bone metabolism....
Oct 07, 2021,
Orthofix Launches Opus Bone Void Filler
Opus Mg Set is a magnesium-based settable bone void filler for orthopedic procedures. ...
Sep 21, 2021,
Anika’s Tactoset Injectable Bone Substitute Now FDA-Cleared for Hardware Augmentation
The injectable bone substitute is now FDA 510(k) cleared for augmenting suture anchor fixation....
Sep 14, 2021,
Kuros Biosciences Gains FDA 510(k) Clearance for MagnetOs Easypack Putty
The clearance follows existing clearances by the FDA for the use of MagnetOs Granules and MagnetOs Putty in the spine....
Sep 09, 2021,
Loading new posts...
No more posts
